243 related articles for article (PubMed ID: 17350989)
1. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
Glocker E; Bogdan C; Kist M
J Antimicrob Chemother; 2007 May; 59(5):874-9. PubMed ID: 17350989
[TBL] [Abstract][Full Text] [Related]
2. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
Wueppenhorst N; Stueger HP; Kist M; Glocker E
J Antimicrob Chemother; 2009 Apr; 63(4):648-53. PubMed ID: 19190100
[TBL] [Abstract][Full Text] [Related]
3. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of Helicobacter pylori resistance to rifamycins.
Hays C; Burucoa C; Lehours P; Tran CT; Leleu A; Raymond J
Helicobacter; 2018 Feb; 23(1):. PubMed ID: 29168600
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the antimycobacterial activities of rifabutin and the relationship between drug-resistance and rpoB mutations of Mycobacterium tuberculosis].
Han XQ; Huang HR; Li YJ; Yu X; Gao JT; Bi ZQ; Chu NH; Li L; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):762-5. PubMed ID: 22321711
[TBL] [Abstract][Full Text] [Related]
7. [Detection of rpoB mutations in rifampicin-resistant Mycobacterium kansasii].
Yoshida S; Suzuki K; Tsuyuguchi K; Iwamoto T; Tomita M; Okada M; Sakatani M
Kekkaku; 2006 Jul; 81(7):475-9. PubMed ID: 16910599
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay.
Posteraro P; Branca G; Sanguinetti M; Ranno S; Cammarota G; Rahimi S; De Carlo M; Posteraro B; Fadda G
J Antimicrob Chemother; 2006 Jan; 57(1):71-8. PubMed ID: 16284224
[TBL] [Abstract][Full Text] [Related]
9. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
[TBL] [Abstract][Full Text] [Related]
10. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene.
Garrido L; Toledo H
Helicobacter; 2007 Oct; 12(5):505-9. PubMed ID: 17760718
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
[TBL] [Abstract][Full Text] [Related]
12. Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales.
Lawson AJ; Elviss NC; Owen RJ
J Antimicrob Chemother; 2005 Aug; 56(2):282-6. PubMed ID: 15958499
[TBL] [Abstract][Full Text] [Related]
13. Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance.
Su Z; Xu H; Zhang C; Shao S; Li L; Wang H; Wang H; Qiu G
Croat Med J; 2006 Jun; 47(3):410-5. PubMed ID: 16758519
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of rifampicin resistance in Haemophilus influenzae.
Cruchaga S; Pérez-Vázquez M; Román F; Campos J
J Antimicrob Chemother; 2003 Dec; 52(6):1011-4. PubMed ID: 14613947
[TBL] [Abstract][Full Text] [Related]
15. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan.
Rimbara E; Noguchi N; Kijima H; Yamaguchi T; Kawai T; Sasatsu M
Int J Antimicrob Agents; 2007 Sep; 30(3):250-4. PubMed ID: 17590317
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
[TBL] [Abstract][Full Text] [Related]
18. DNA sequence analysis of rdxA and frxA from paired metronidazole-sensitive and -resistant Helicobacter pylori isolates obtained from patients with heteroresistance.
Matteo MJ; Pérez CV; Domingo MR; Olmos M; Sanchez C; Catalano M
Int J Antimicrob Agents; 2006 Feb; 27(2):152-8. PubMed ID: 16426819
[TBL] [Abstract][Full Text] [Related]
19. The rdxA gene plays a more major role than frxA gene mutation in high-level metronidazole resistance of Helicobacter pylori in Taiwan.
Yang YJ; Wu JJ; Sheu BS; Kao AW; Huang AH
Helicobacter; 2004 Oct; 9(5):400-7. PubMed ID: 15361078
[TBL] [Abstract][Full Text] [Related]
20. Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients.
Kim JM; Kim JS; Kim N; Kim YJ; Kim IY; Chee YJ; Lee CH; Jung HC
J Microbiol Biotechnol; 2008 Sep; 18(9):1584-9. PubMed ID: 18852516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
